Organically Human on MSN14d
Blood pressure medication was recalled because it may give you cancer insteadIf you're on a drug for high blood pressure or heart failure, it's pretty likely that you're doing your best to keep your ...
Sacubitril/valsartan or Sac/Val was launched in the US in July 2015, under brand name Entresto and in five European markets ...
About The Study: In this post hoc pooled analysis of 13,194 patients with chronic heart failure (HF) in the PARADIGM-HF and PARAGON-HF randomized clinical trials, sacubitril/valsartan significantly ...
Biotechnology firm Biocon said its subsidiary has received approval from the US health regulator to market a generic ...
Biocon Pharma has received approval of its ANDA for Sacubitril/Valsartan Tablets, in 24 mg/26 mg, 49 mg/51 mg and 97 mg/103 ...
In patients with heart failure with reduced ejection fraction across multiple kidney risk categories, sacubitril/valsartan therapy is safe and effective. Sacubitril/valsartan is safe and effective ...
Topline numbers show a significant reduction in major events in preserved heart failure, and now final results from the ...
Biocon's subsidiary, Biocon Pharma, has received approval from the US Food and Drug Administration (USFDA) to market a generic version of Sacubitril/Valsartan tablets. This medication addresses ...
Biocon's subsidiary receives USFDA approval for generic Sacubitril/Valsartan Tablets, a medication used to treat chronic ...
OnArni 50mg priced at just INR 8/-per tablet is now accessible and affordable for all Indian heart failure patients. OnArni ...
This leaflet answers some common questions about AMLODIPINE/VALSARTAN/HCT NOVARTIS. It does not contain all the available information. It does not take the place of talking to your doctor or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback